Ranitidine bismuth citrate therapy regimens for treatment of Helicobacter pylori infection: a review.
Gisbert
J P
JP
Department of Gastroenterology, University Hospital "La Princesa", Madrid, Spain.
Pajares
J M
JM
Valle
J
J
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D001729:Bismuth / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D004338:Drug Combinations; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D010865:Pilot Projects; D011899:Ranitidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D004338:Drug Combinations; C073340:ranitidine bismuth citrate; D011899:Ranitidine; D001729:Bismuth